References analysis of the Wikipedia article "Proteína C" in the Galician version

doi.org

dx.doi.org

Nicolaes GA, Dahlbäck B (February 2003). "Congenital and acquired activated protein C resistance". Seminars in Vascular Medicine 3 (1): 33–46. PMID 15199491. doi:10.1055/s-2003-38331.

Foster DC, Yoshitake S, Davie EW (July 1985). "The nucleotide sequence of the gene for human protein C". Proceedings of the National Academy of Sciences of the United States of America 82 (14): 4673–7. PMC 390448. PMID 2991887. doi:10.1073/pnas.82.14.4673.

Mosnier LO, Zlokovic BV, Griffin JH (April 2007). "The cytoprotective protein C pathway". Blood 109 (8): 3161–72. PMID 17110453. doi:10.1182/blood-2006-09-003004.

Eichacker PQ, Natanson C, Danner RL (October 2006). "Surviving sepsis--practice guidelines, marketing campaigns, and Eli Lilly". The New England Journal of Medicine 355 (16): 1640–2. PMID 17050887. doi:10.1056/NEJMp068197.

Martí-Carvajal AJ, Solà I, Gluud C, Lathyris D, Cardona AF (2012-12-12). "Human recombinant protein C for severe sepsis and septic shock in adult and paediatric patients". The Cochrane Database of Systematic Reviews 12: CD004388. ISSN 1469-493X. PMID 23235609. doi:10.1002/14651858.CD004388.pub6.

Kylat, Ranjit; Ohlsson, Arne (April 18, 2012). "Recombinant human activated protein C for severe sepsis in neonates.". Cochrane Database of Systematic Reviews (4): CD005385. doi:10.1002/14651858.CD005385.pub3.

Kisiel W, Ericsson LH, Davie EW (November 1976). "Proteolytic activation of protein C from bovine plasma". Biochemistry 15 (22): 4893–900. PMID 990250. doi:10.1021/bi00667a022.

Mosnier LO, Griffin JH (2006). "Protein C anticoagulant activity in relation to anti-inflammatory and anti-apoptotic activities". Frontiers in Bioscience 11: 2381–99. PMID 16720321. doi:10.2741/1977.

Kisiel W, Canfield WM, Ericsson LH, Davie EW (December 1977). "Anticoagulant properties of bovine plasma protein C following activation by thrombin". Biochemistry 16 (26): 5824–31. PMID 588557. doi:10.1021/bi00645a029.

Vehar GA, Davie EW (February 1980). "Preparation and properties of bovine factor VIII (antihemophilic factor)". Biochemistry 19 (3): 401–10. PMID 7356933. doi:10.1021/bi00544a001.

Griffin JH, Evatt B, Zimmerman TS, Kleiss AJ, Wideman C (November 1981). "Deficiency of protein C in congenital thrombotic disease". The Journal of Clinical Investigation 68 (5): 1370–3. PMC 370934. PMID 6895379. doi:10.1172/JCI110385.

Goldenberg NA, Manco-Johnson MJ (November 2008). "Protein C deficiency". Haemophilia 14 (6): 1214–21. PMID 19141162. doi:10.1111/j.1365-2516.2008.01838.x.

Beckmann RJ, Schmidt RJ, Santerre RF, Plutzky J, Crabtree GR, Long GL (July 1985). "The structure and evolution of a 461 amino acid human protein C precursor and its messenger RNA, based upon the DNA sequence of cloned human liver cDNAs". Nucleic Acids Research 13 (14): 5233–47. PMC 321861. PMID 2991859. doi:10.1093/nar/13.14.5233.

Taylor FB, Chang A, Esmon CT, D'Angelo A, Vigano-D'Angelo S, Blick KE (March 1987). "Protein C prevents the coagulopathic and lethal effects of Escherichia coli infusion in the baboon". The Journal of Clinical Investigation 79 (3): 918–25. PMC 424237. PMID 3102560. doi:10.1172/JCI112902.

Dahlbäck B, Carlsson M, Svensson PJ (February 1993). "Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C". Proceedings of the National Academy of Sciences of the United States of America 90 (3): 1004–8. PMC 45799. PMID 8430067. doi:10.1073/pnas.90.3.1004.

Bertina RM, Koeleman BP, Koster T, Rosendaal FR, Dirven RJ, de Ronde H, van der Velden PA, Reitsma PH (May 1994). "Mutation in blood coagulation factor V associated with resistance to activated protein C". Nature 369 (6475): 64–7. PMID 8164741. doi:10.1038/369064a0.

PROWESS: recombinant Human Activated PROtein C Worldwide Evaluation in Severe Sepsis; Bernard GR, Vincent JL, Laterre PF, LaRosa SP, Dhainaut JF, Lopez-Rodriguez A, Steingrub JS, Garber GE, Helterbrand JD, Ely EW, Fisher CJ (March 2001). "Efficacy and safety of recombinant human activated protein C for severe sepsis". The New England Journal of Medicine 344 (10): 699–709. PMID 11236773. doi:10.1056/NEJM200103083441001.

Hosac AM (April 2002). "Drotrecogin alfa (activated): the first FDA-approved treatment for severe sepsis". Proceedings 15 (2): 224–7. PMC 1276518. PMID 16333441. doi:10.1080/08998280.2002.11927844.

Riewald M, Petrovan RJ, Donner A, Mueller BM, Ruf W (June 2002). "Activation of endothelial cell protease activated receptor 1 by the protein C pathway". Science 296 (5574): 1880–2. PMID 12052963. doi:10.1126/science.1071699.

Wildhagen KC, Lutgens E, Loubele ST, ten Cate H, Nicolaes GA (December 2011). "The structure-function relationship of activated protein C. Lessons from natural and engineered mutations". Thrombosis and Haemostasis 106 (6): 1034–45. PMID 22072231. doi:10.1160/TH11-08-0522.

D'Ursi P, Marino F, Caprera A, Milanesi L, Faioni EM, Rovida E (2007). "ProCMD: a database and 3D web resource for protein C mutants". BMC Bioinformatics. 8 Suppl 1: S11. PMC 1885840. PMID 17430555. doi:10.1186/1471-2105-8-S1-S11.

Weiler-Guettler H, Christie PD, Beeler DL, Healy AM, Hancock WW, Rayburn H, Edelberg JM, Rosenberg RD (May 1998). "A targeted point mutation in thrombomodulin generates viable mice with a prethrombotic state". The Journal of Clinical Investigation 101 (9): 1983–91. PMC 508785. PMID 9576763. doi:10.1172/JCI2006.

Gu JM, Crawley JT, Ferrell G, Zhang F, Li W, Esmon NL, Esmon CT (November 2002). "Disruption of the endothelial cell protein C receptor gene in mice causes placental thrombosis and early embryonic lethality". The Journal of Biological Chemistry 277 (45): 43335–43. PMID 12218060. doi:10.1074/jbc.M207538200.

Esmon CT (September 2003). "The protein C pathway". Chest 124 (3 Suppl): 26S–32S. PMID 12970121. doi:10.1378/chest.124.3_suppl.26S.

Slungaard A, Vercellotti GM, Tran T, Gleich GJ, Key NS (April 1993). "Eosinophil cationic granule proteins impair thrombomodulin function. A potential mechanism for thromboembolism in hypereosinophilic heart disease". The Journal of Clinical Investigation 91 (4): 1721–30. PMC 288152. PMID 8386194. doi:10.1172/JCI116382.

España F, Berrettini M, Griffin JH (August 1989). "Purification and characterization of plasma protein C inhibitor". Thrombosis Research 55 (3): 369–84. PMID 2551064. doi:10.1016/0049-3848(89)90069-8.

Nicolaes GA, Tans G, Thomassen MC, Hemker HC, Pabinger I, Varadi K, Schwarz HP, Rosing J (September 1995). "Peptide bond cleavages and loss of functional activity during inactivation of factor Va and factor VaR506Q by activated protein C". The Journal of Biological Chemistry 270 (36): 21158–66. PMID 7673148. doi:10.1074/jbc.270.36.21158.

Nicolaes GA, Bock PE, Segers K, Wildhagen KC, Dahlbäck B, Rosing J (July 2010). "Inhibition of thrombin formation by active site mutated (S360A) activated protein C". The Journal of Biological Chemistry 285 (30): 22890–900. PMC 2906281. PMID 20484050. doi:10.1074/jbc.M110.131029.

Wildhagen KC, Schrijver R, Beckers L, ten Cate H, Reutelingsperger CP, Lutgens E, Nicolaes GA (July 2014). "Effects of exogenous recombinant APC in mouse models of ischemia reperfusion injury and of atherosclerosis". PLoS One 9 (7): e101446. PMC 4102480. PMID 25032959. doi:10.1371/journal.pone.0101446.

Ansell J, Hirsh J, Hylek E, Jacobson A, Crowther M, Palareti G (June 2008). "Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)". Chest 133 (6 Suppl): 160S–198S. PMID 18574265. doi:10.1378/chest.08-0670.

Dahlbäck B (January 2003). "The discovery of activated protein C resistance". Journal of Thrombosis and Haemostasis 1 (1): 3–9. PMID 12871530. doi:10.1046/j.1538-7836.2003.00016.x.

Gillrie MR, Lee K, Gowda DC, Davis SP, Monestier M, Cui L, Hien TT, Day NP, Ho M (March 2012). "Plasmodium falciparum histones induce endothelial proinflammatory response and barrier dysfunction". The American Journal of Pathology 180 (3): 1028–39. PMC 3448071. PMID 22260922. doi:10.1016/j.ajpath.2011.11.037.

Abraham E, Laterre PF, Garg R, Levy H, Talwar D, Trzaskoma BL, François B, Guy JS, Brückmann M, Rea-Neto A, Rossaint R, Perrotin D, Sablotzki A, Arkins N, Utterback BG, Macias WL (September 2005). "Drotrecogin alfa (activated) for adults with severe sepsis and a low risk of death". The New England Journal of Medicine 353 (13): 1332–41. PMID 16192478. doi:10.1056/NEJMoa050935.

Martí-Carvajal AJ, Solà I, Lathyris D, Cardona AF (2011-04-13). Martí-Carvajal AJ, ed. "Human recombinant activated protein C for severe sepsis". The Cochrane Database of Systematic Reviews (4): CD004388. PMID 21491390. doi:10.1002/14651858.CD004388.pub4.

Griffin JH, Fernández JA, Mosnier LO, Liu D, Cheng T, Guo H, Zlokovic BV (2006). "The promise of protein C". Blood Cells, Molecules & Diseases 36 (2): 211–6. PMID 16464623. doi:10.1016/j.bcmd.2005.12.023.

nih.gov

ncbi.nlm.nih.gov

Nicolaes GA, Dahlbäck B (February 2003). "Congenital and acquired activated protein C resistance". Seminars in Vascular Medicine 3 (1): 33–46. PMID 15199491. doi:10.1055/s-2003-38331.

Mosnier LO, Zlokovic BV, Griffin JH (April 2007). "The cytoprotective protein C pathway". Blood 109 (8): 3161–72. PMID 17110453. doi:10.1182/blood-2006-09-003004.

Mammen EF, Thomas WR, Seegers WH (December 1960). "Activation of purified prothrombin to autoprothrombin I or autoprothrombin II (platelet cofactor II or autoprothrombin II-A)". Thrombosis Et Diathesis Haemorrhagica 5: 218–49. PMID 13765990.

Stenflo J (January 1976). "A new vitamin K-dependent protein. Purification from bovine plasma and preliminary characterization". The Journal of Biological Chemistry 251 (2): 355–63. PMID 1245477.

Kisiel W, Ericsson LH, Davie EW (November 1976). "Proteolytic activation of protein C from bovine plasma". Biochemistry 15 (22): 4893–900. PMID 990250. doi:10.1021/bi00667a022.

Vehar GA, Davie EW (February 1980). "Preparation and properties of bovine factor VIII (antihemophilic factor)". Biochemistry 19 (3): 401–10. PMID 7356933. doi:10.1021/bi00544a001.

Walker FJ (June 1980). "Regulation of activated protein C by a new protein. A possible function for bovine protein S". The Journal of Biological Chemistry 255 (12): 5521–4. PMID 6892911.

Goldenberg NA, Manco-Johnson MJ (November 2008). "Protein C deficiency". Haemophilia 14 (6): 1214–21. PMID 19141162. doi:10.1111/j.1365-2516.2008.01838.x.

Esmon NL, DeBault LE, Esmon CT (May 1983). "Proteolytic formation and properties of gamma-carboxyglutamic acid-domainless protein C". The Journal of Biological Chemistry 258 (9): 5548–53. PMID 6304092.

Esmon CT (September 2003). "The protein C pathway". Chest 124 (3 Suppl): 26S–32S. PMID 12970121. doi:10.1378/chest.124.3_suppl.26S.

Dahlbäck B (January 2003). "The discovery of activated protein C resistance". Journal of Thrombosis and Haemostasis 1 (1): 3–9. PMID 12871530. doi:10.1046/j.1538-7836.2003.00016.x.

Martí-Carvajal AJ1, Solà I, Gluud C, Lathyris D, Cardona AF. Human recombinant protein C for severe sepsis and septic shock in adult and paediatric patients.Cochrane Database Syst Rev. 2012 Dec 12;12:CD004388. doi: 10.1002/14651858.CD004388.pub6. PMID 23235609 update

worldcat.org

Proteína C (Galician Wikipedia)

archive.org

doi.org

dx.doi.org

nih.gov

ncbi.nlm.nih.gov

worldcat.org